04:20:45 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



Q:ILMN - ILLUMINA INC - https://www.illumina.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ILMN - Q2.0118.00·120.170.5119.72-13.89-10.44,450.9533,73247,888125.99  128.1632  117.67155.4699  68.7019:56:09Feb 0515 min RT 2¢

Recent Trades - Last 10 of 47888
Time ETExPriceChangeVolume
19:56:09Q119.84-13.7711
19:55:03Q119.85-13.761
19:53:50Q119.84-13.771
19:51:54Q119.85-13.761
19:51:24Q119.05-14.5610
19:50:24Q119.726-13.884163
19:50:08Q119.8597-13.75031
19:48:27Q120.67-12.941
19:46:39Q119.84-13.7774
19:43:41Q119.80-13.818

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-02-05 16:05U:ILMNNews ReleaseIllumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025
2026-02-03 09:15U:ILMNNews ReleaseIllumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo(TM), supporting critical conservation genetics efforts globally
2026-01-30 09:09U:ILMNNews ReleaseStandard BioTools Completes Sale of SomaLogic to Illumina
2026-01-30 09:05U:ILMNNews ReleaseIllumina completes acquisition of SomaLogic
2026-01-20 09:15U:ILMNNews ReleaseIllumina secures CMS reimbursement for TruSight(TM) Oncology Comprehensive, expanding access to precision oncology
2026-01-13 09:15U:ILMNNews ReleaseIllumina introduces Billion Cell Atlas to accelerate AI and drug discovery
2026-01-13 09:00U:ILMNNews ReleaseIllumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
2026-01-12 16:05U:ILMNNews ReleaseIllumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026
2026-01-08 16:30U:ILMNNews ReleaseIllumina Appoints Dr. Eric Green as Chief Medical Officer
2026-01-06 09:15U:ILMNNews ReleaseIllumina launches powerful software for connected, intuitive, and scalable multiomic analysis
2025-12-16 16:05U:ILMNNews ReleaseIllumina To Webcast Upcoming Investor Conference
2025-12-14 16:42U:ILMNNews Release/C O R R E C T I O N -- MyOme, Inc/
2025-12-11 09:15U:ILMNNews ReleaseIllumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually
2025-11-12 12:00U:ILMNNews ReleaseIllumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study
2025-11-11 16:05U:ILMNNews ReleaseIllumina To Webcast Upcoming Investor Conference
2025-11-10 12:15U:ILMNNews ReleaseIllumina(TM) Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks
2025-11-05 17:16U:ILMNNews ReleaseIllumina Responds to Positive Updates from Chinese Ministry of Commerce
2025-10-30 16:05U:ILMNNews ReleaseIllumina Reports Financial Results for Third Quarter of Fiscal Year 2025
2025-10-15 09:15U:ILMNNews ReleaseIllumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
2025-10-15 09:15U:ILMNNews ReleaseIllumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot